PPG Biosensors Industry Overview

The global PPG biosensors market
size was valued at USD 344.0 million in 2020 and is expected to expand at a
compound annual growth rate (CAGR) of 12.1% from 2021 to 2028. The use of PPG
technology as an alternative heart rate monitoring strategy has increased
rapidly, primarily owing to its ease of use, wearing comfort for its consumers,
and cost-effectiveness. PPG is more flexible that can be used in a wider range
of applications, such as watches, rings, patches, and earbuds.

Wearable wellness tracking technologies,
such as smartwatches and fitness trackers, have intrigued the attention of
consumers in recent years. Smart wearables are integrated with PPG biosensors
that are used to measure heart rate, blood oxygen saturation, and blood
pressure. For instance, Valencell’s PerformTek PPG biosensor technology is the
only continuous heart rate sensor technology proven accurate during virtually
any exercise and in virtually any environment.

Gather more insights about the market drivers, restraints and growth of the
Global PPG Biosensors market

The COVID-19 pandemic has highlighted the importance of harnessing and
leveraging digital technology for remote patient tracking. We see a need for
more robust disease identification and control of patient and public wellbeing,
which might be assisted by wearable devices, as existing viral testing and
vaccines are slow to develop. COVID-19, like other viral illnesses, is
associated with several physiological changes that can be tracked with wearable
biosensors. Numerous cardiac rhythm indicators, such as Heart Rate (HR), Heart
Rate Variability (HRV), Blood-volume Saturation, and Respiration Rate (RR),
might serve as possible markers of COVID-19 infection and are already measured
by smart wearables that use PPG technology. Companies are developing innovative
technologies to facilitate healthcare staff in reducing transmission risks
while still increasing clinician and patient safety. For instance, in May 2019,
Masimo received FDA clearance for its Tetherless Radius PPG biosensors that aid
the placement of point-of-care monitors outside a patient’s room safeguarding
constant monitoring from a distance.

The increasing prevalence of
cardiovascular disorders is majorly expected to propel the growth of the market
for PPG biosensors over the estimated study period. For instance, according to
the American Heart Association, Inc., at least 48.0% of U.S. adults have some
form of cardiovascular disease, and by 2035, more than 130 million adults, or
45.1% of the U.S. population is estimated to have some CVD. Thereby, the
association of this technique with advances in technology seems to
proportionate the detection of cardiopathies rapidly, enhance medical treatment
with remote control and surveillance of the patient in a healthcare setting,
and minimize the number of deaths caused by cardiovascular diseases.

PPG is a non-invasive, inexpensive
technique as compared to the ECG biosensors and also it can be easily
incorporated on several sites such as a finger, toe, ear, wrist, chest, and
head for measuring the signal. The non-invasive PPG technique for measuring
SpO2 and HR is widely used in personal handheld devices and clinical pulse
oximetry due to its simplicity and ability to perform continuous readings. It
is considered a compact, low-cost device with a basic application that is also
non-invasive and applicable in a variety of settings. In addition to the
previously stated characteristics, the development of signal processing
algorithms adds robustness that contributes to the advancement of this
technology. Hence, owing to several advantages offered by PPG, the demand for
these biosensors will surge in forthcoming years, leading to market growth.

Browse through Grand View Research's Healthcare Industry Related Reports

Biosensors Market - The global
biosensors market size was valued at USD 24.9 billion in 2021 and is
expected to expand at a compound annual growth rate (CAGR) of 8.0% from
2022 to 2030.

Glucose Biosensors Market - The
global glucose biosensors market size was valued at USD 10,206.3 million
in 2021 and is anticipated to expand at a CAGR of 7.9% during the forecast
period.

PPG Biosensors Industry Segmentation

Grand View Research has segmented
the global PPG biosensors market on the basis of product, application, and
region:

PPG Biosensors Product Outlook
(Revenue, USD Million, 2016 - 2028)

Pulse Oximeters

Smart Watches

Smart Wrist Bands

Other Products

PPG Biosensors Application
Outlook (Revenue, USD Million, 2016 - 2028)

Heart Rate Monitoring

Blood-oxygen Saturation

Blood Pressure

Other Applications

PPG Biosensors Regional Outlook
(Revenue, USD Million, 2016 - 2028)

North America

Europe

Asia Pacific

Latin America

MEA (Middle East & Africa)

Market Share Insights:

Nov 2020: Realme
launched Realme Watch S with a PPG sensor and a SpO2 sensor across the
globe.

August 2020:
Valencell launched the world’s 1st calibration-free Blood Pressure (BP)
sensor system for integration in hearables and wearables. The technology
uses Photoplethysmography (PPG) and inertial sensors.

Key Companies profiled:

Some prominent players in the global
PPG Biosensors Industry include

Valencell, Inc.

Maxim Integrated

Murata Manufacturing Co., Ltd.

Silicon Laboratories

Mediatek

ams AG

Order a free sample PDF of the PPG Biosensors
Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based
market research and consulting company, provides syndicated as well as
customized research reports and consulting services. Registered in California
and headquartered in San Francisco, the company comprises over 425 analysts and
consultants, adding more than 1200 market research reports to its vast database
each year. These reports offer in-depth analysis on 46 industries across 25
major countries worldwide. With the help of an interactive market intelligence
platform, Grand View Research Helps Fortune 500 companies and renowned academic
institutes understand the global and regional business environment and gauge
the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter